Back to Search
Start Over
Risk-reducing salpingo-oophorectomy and ovarian cancer screening in 1077 women after BRCA testing.
- Source :
-
JAMA internal medicine [JAMA Intern Med] 2013 Jan 28; Vol. 173 (2), pp. 96-103. - Publication Year :
- 2013
-
Abstract
- Background: For women at potentially increased risk for ovarian cancer, data regarding screening and risk reduction are limited. Previous studies have reported on the behaviors of BRCA mutation carriers, but less is known about the behaviors of non- BRCA carriers. We surveyed a large cohort of women after BRCA testing to identify the prevalence and posttest predictors of risk-reducing and screening interventions.<br />Methods: A median of 3.7 years after BRCA testing, 1447 women who received genetic counseling and BRCA testing at 2 hospital sites were surveyed, with a 77.6% response rate. We analyzed data from 1077 survey respondents. We performed univariate and multivariate logistic regression analyses to identify predictors of risk-reducing salpingo-oophorectomy (RRSO), screening transvaginal ultrasonography (TVUS), and screening serum cancer antigen 125 (CA-125).<br />Results: Among the respondents, 201 women (18.7%) received positive test results for a deleterious mutation, 103 women (9.6%) received true-negative results, and 773 women (71.8%) received uninformative results. Overall, 19.1% of eligible women underwent RRSO and 39.6% used screening procedures. A positive BRCA result predicted RRSO (odds ratio [OR], 28.1; 95% CI, 16.2-48.6), TVUS (9.5 [4.3-21.0]), and serum CA-125 (13.0 [5.5-29.0]). Similarly, a true-negative BRCA result reduced the OR for RRSO (0.1 [0.0-0.6]), TVUS (0.2 [0.1-0.5]), and serum CA-125 (0.3 [0.1-0.7]). Of the 71.8% of women who received uninformative results after BRCA testing, 12.3% subsequently underwent RRSO, 33.8% reported ever having undergone screening serum CA-125 since BRCA testing, and 37.3% reported ever having undergone screening TVUS since BRCA testing.<br />Conclusions: Results of BRCA testing strongly predict RRSO and ovarian cancer screening. Use of RRSO and ovarian screening was reported in a sizable percentage of non- BRCA carriers despite insufficient data to determine the effectiveness of these interventions.
- Subjects :
- Adult
CA-125 Antigen blood
Female
Humans
Middle Aged
Ovarian Neoplasms genetics
Ovarian Neoplasms prevention & control
Risk Factors
Genes, BRCA1
Genes, BRCA2
Mass Screening statistics & numerical data
Ovarian Neoplasms diagnosis
Ovariectomy statistics & numerical data
Salpingectomy statistics & numerical data
Subjects
Details
- Language :
- English
- ISSN :
- 2168-6114
- Volume :
- 173
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- JAMA internal medicine
- Publication Type :
- Academic Journal
- Accession number :
- 23247828
- Full Text :
- https://doi.org/10.1001/2013.jamainternmed.962